Aclaris Therapeutics (ACRS) Return on Sales (QoQ) (2017 - 2026)

Aclaris Therapeutics (ACRS) Return on Sales (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.00
Dec 31, 2025 -18.00
Sep 30, 2025 5.00
Jun 30, 2025 2.00
Mar 31, 2025 -1.00
Dec 31, 2024 -10.00
Sep 30, 2024 2.00
Jun 30, 2024 3.00
Mar 31, 2024 -7.00
Dec 31, 2023 3.00
Sep 30, 2023 17.00
Jun 30, 2023 -7.00
Mar 31, 2023 14.00
Dec 31, 2022 -26.00
Sep 30, 2022 19.00
Jun 30, 2022 5.00
Mar 31, 2022 97.00
Dec 31, 2021 -100.00
Sep 30, 2021 -4.00
Jun 30, 2021 14.00